Assetmark Inc. Lowers Stock Holdings in Cigna Group $CI

Assetmark Inc. reduced its stake in shares of Cigna Group (NYSE:CI) by 3.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 59,699 shares of the health services provider’s stock after selling 2,110 shares during the quarter. Assetmark Inc.’s holdings in Cigna Group were worth $16,431,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of CI. Harbor Capital Advisors Inc. lifted its holdings in Cigna Group by 119.5% in the third quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after buying an additional 49 shares during the period. Beacon Financial Strategies CORP bought a new stake in Cigna Group in the 4th quarter worth approximately $28,000. Lodestone Wealth Management LLC bought a new stake in Cigna Group in the 4th quarter worth approximately $32,000. Collier Financial bought a new stake in shares of Cigna Group during the 3rd quarter valued at $34,000. Finally, True Wealth Design LLC grew its position in shares of Cigna Group by 116.4% during the 4th quarter. True Wealth Design LLC now owns 158 shares of the health services provider’s stock valued at $43,000 after acquiring an additional 85 shares during the period. 86.99% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently weighed in on CI. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Jefferies Financial Group upped their target price on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. TD Cowen increased their price objective on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research note on Monday, February 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. Finally, Mizuho set a $325.00 price target on shares of Cigna Group in a report on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $332.63.

Cigna Group Stock Up 2.8%

Shares of NYSE CI opened at $276.17 on Friday. The company’s 50-day simple moving average is $276.17 and its 200-day simple moving average is $278.22. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The firm has a market cap of $72.78 billion, a price-to-earnings ratio of 12.45, a price-to-earnings-growth ratio of 0.93 and a beta of 0.26. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. Cigna Group’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Equities analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were issued a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.3%. The ex-dividend date was Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s dividend payout ratio (DPR) is presently 28.13%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.